Status:

COMPLETED

VisONE Heart Failure Study: Pilot

Lead Sponsor:

VisCardia Inc.

Collaborating Sponsors:

Clinical Accelerator

University of Glasgow

Conditions:

Heart Failure With Reduced Ejection Fraction, HFrEF

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The VisONE HF pilot is a feasibility pilot for evaluating the benefits and risks of chronically delivering Asymptomatic Diaphragmatic Stimulation in medical refractory heart failure patients using the...

Detailed Description

This 12 month study is intended to validate the early benefits observed with Asymptomatic Diaphragmatic Stimulation (ADS) as a primary form of heart failure therapy with low rates and severity of adve...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • NYHA class II/III medical refractory despite guideline indicated heart failure medications
  • Sinus rhythm with \<10% ectopy
  • EF ≤ 35%
  • NT-proBNP \> 500 (250 if on loop diuretics)
  • Exclusion Criteria
  • 6MHW \>500 m or \< 200 m
  • Resting HR \> 140 bpm
  • SBP \<80 mmHg or \> 170 mmHg
  • Serum creatine \> 2.5 mg/dL
  • Ventricular dyssynchrony by ECG with QRS ≥ 140ms
  • Unstable angina, AMI, CABG, PTCA, CVA/TIA, persistent AF, NSVT, sustained VT or VF, or DCCV within 3 months
  • Intermittent inotropic drug treatment
  • Existing pacemaker or indications for a pacemaker
  • Severe primary pulmonary disease including pulmonary arterial hypertension or severe COPD, or other respiratory or lung diseases where FEV \< 50% or any condition with severe diaphragmatic dysfunction
  • Previous open laparotomy within 1 year or contraindications to laparoscopy, as determined by implanting physician
  • Known or active intra-abdominal infections, or known intra-abdominal pathology
  • Previous thoracic or abdominal organ transplant, transplant waiting list
  • Pregnancy

Exclusion

    Key Trial Info

    Start Date :

    July 25 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 12 2019

    Estimated Enrollment :

    15 Patients enrolled

    Trial Details

    Trial ID

    NCT03484780

    Start Date

    July 25 2018

    End Date

    December 12 2019

    Last Update

    May 20 2020

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Tbilisi Heart and Vascular Clinic

    Tbilisi, Georgia, 0159

    2

    Kyiv City Heart Center

    Kiev, Ukraine

    3

    Amosov National Institute of Cardiovascular Surgery

    Kyiv, Ukraine